Cognitive Enhancement Drug Use Among Future Physicians: Findings from a Multi-Institutional Census of Medical Students
Nonmedical use of prescription psychostimulants such as methylphenidate and amphetamine salts for the purpose of cognitive enhancement is a growing trend, particularly in educational environments. To our knowledge, no recent studies have evaluated the use of these psychostimulants in a medical academic setting.
To conduct an online census of psychostimulant use among medical students.
In 2011, we conducted a multi-institutional census using a 31–48 item online survey regarding use of prescription psychostimulants.
2,732 actively enrolled medical students at four private and public medical schools in the greater Chicago area.
Prevalence and correlates of psychostimulant use
1,115 (41 %) of students responded to the web-based questionnaire (range 26–47 % among schools). On average, students were 25.1 years of age (SD = 2.7, range 20–49), and single (70 %). Overall, 18 % (198/1,115) of this medical student sample had used prescription psychostimulants at least once in their lifetime, with first use most often in college. Of these, 11 % (117/1,115) of students reported use during medical school (range 7–16 % among schools). Psychostimulant use was significantly correlated with use of barbiturates, ecstasy, and tranquilizers (Pearson’s correlation r > 0.5, Student’s t-test p < 0.01); male gender (21 % male versus 15 % female, Chi squared p = 0.007); and training at a medical school which by student self-report determined class rank (68 % versus 51 %, Chi-squared p = 0.018). Non-users were more likely to be first year students (Chi-squared p = 0.048) or to have grown up outside of the United States (Chi-squared p = 0.013).
Use of psychostimulants, including use without a prescription, is common among medical students. Further study of the side effects, medical implications, and use during post-graduate medical training and medical practice is needed to inform evidence-based policy.
KEY WORDScognitive enhancement nootropics amphetamine salts methylphenidate medical students drug use
- 2.Prescription drug abuse: a fast-growing problem. NIH Medline Plus. 2011;6(3):21.Google Scholar
- 5.American Academy of Family Physicians Conditions A to Z. Attention Deficit Hyperactivity Disorder (ADHD) and Attention Deficit Disorder (ADD) 2009.; http://online.statref.com/document.aspx?fxid=99&docid=11. Accessed Feburary 23, 2012.
- 6.Ropper A, Brown R. Adams and Victor’s Principles of Neurology. 8th ed. New York: The McGraw-Hill Publishing Company; 2005.Google Scholar
- 11.Porter RS. The Merk Manual Home Health Handbook. In: Porter RS, ed. Amphetamines: Merk; 2011: http://www.merckmanuals.com/home/special_subjects/drug_use_and_abuse/amphetamines.html?qt=amphetamines&alt=sh. Accessed Feburary 23, 2012.
- 13.United States Congress. U.S. Substances Control Act. Vol 84 Stat. 12421970.Google Scholar
- 17.Flaherty JA, Richman JA. Substance use and addiction among medical students, residents, and physicians. Psychiatr Clin N Am. 1993;16(1):189–97.Google Scholar
- 18.Rai D, Gaete J, Girotra S, Pal HR, Araya R. Substance use among medical students: time to reignite the debate? Nat Med J India. 2008;21(2):75–8.Google Scholar
- 20.Shyangwa PM, Joshi D, Lal R. Alcohols and other substance use/abuse among junior doctors and medical students in a teaching institute. JNMA. 2007;46(167):126–9.Google Scholar
- 22.Harris S. “I Don’t See It as a Problem”: More Medical Students Taking Prescription Stimulants, Few See Cause for Concern. AAMC Reporter. 2009;June Edition.Google Scholar
- 23.Johnston LD, O’Malley PM, Bachman JG, Schulenberg JE. Monitoring the future national survey results on drug use, 1975–2011. Annu Vol Trends Drug Use Relat Factors. 2012;2:314.Google Scholar
- 33.Marsden P, Wright J. Handbook of Survey Research. 2nd ed: Emerald Publishing Group Limited; 2010.Google Scholar